Lifevantage (LFVN) Net Margin (2010 - 2026)
Lifevantage's (LFVN) quarterly Net Margin came in at 16.22% in Q2 2026, up 1573.0% on a YoY basis from 0.97% in Q2 2025, and up 422.99% quarter-over-quarter from 3.1% in Q1 2026.
Powered by 
Analysis
Lifevantage (LFVN) Net Margin (2010 - 2026) Analysis & Trends
Lifevantage (LFVN) has reported Net Margin for 17 consecutive years, with 16.22% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin rose 1573.0% year-over-year to 16.22%; the trailing twelve-month figure through Jun 2026 stood at 3.27% (down 26.0% YoY), and the FY2026 full-year result was 2.62%, down 93.0% from the prior year.
- Net Margin rose to 16.22% in Q2 2026 per LFVN's latest filing, from 3.1% in the prior quarter.
- Across five years, Net Margin topped out at 16.22% in Q2 2026 and bottomed at 2.78% in Q2 2022.
- Historically, Net Margin has averaged 2.71% across 5 years, with a median of 2.47% in 2022.
- The sharpest annual moves came in 2022 and 2026: Net Margin slumped 1180 bps in 2022, then jumped 1573 bps in 2026.
- Over 5 years, Net Margin stood at 1.97% in 2022, then jumped by 40 bps to 1.19% in 2023, then surged by 417 bps to 3.76% in 2024, then tumbled by 85 bps to 0.56% in 2025, then jumped by 2808 bps to 16.22% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 16.22%, 3.1%, and 0.56% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.52 Bn | 69.15 Bn | 3.30 Bn | 13.41% |
| 2 | Kenvue | 34.33 Bn | 33.22 Bn | 2.30 Bn | 11.53% |
| 3 | Kimberly Clark | 32.97 Bn | 32.01 Bn | 1.60 Bn | 7.04% |
| 4 | Bath & Body Works | 3.76 Bn | 2.96 Bn | 692.00 Mn | 7.79% |
| 5 | Prestige Consumer Healthcare | 2.29 Bn | 2.23 Bn | - | - |
| 6 | Perrigo | 1.92 Bn | 1.52 Bn | 313.90 Mn | 7.27% |
| 7 | Herbalife | 1.29 Bn | 915.90 Mn | 1.03 Bn | -2.00% |
| 8 | Edgewell Personal Care | 1.21 Bn | 814.87 Mn | 242.50 Mn | 2.40% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Lifevantage | 80.28 Mn | 65.36 Mn | 33.04 Mn | 16.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.22% |
| Mar 31, 2026 | 3.10% |
| Dec 31, 2025 | 0.56% |
| Sep 30, 2025 | 4.50% |
| Jun 30, 2025 | 0.50% |
| Mar 31, 2025 | 5.94% |
| Dec 31, 2024 | 3.76% |
| Sep 30, 2024 | 3.77% |
| Jun 30, 2024 | 2.67% |
| Mar 31, 2024 | 3.36% |
| Dec 31, 2023 | -1.19% |
| Sep 30, 2023 | 1.22% |
| Jun 30, 2023 | 3.68% |
| Mar 31, 2023 | 1.90% |
| Dec 31, 2022 | -1.97% |
| Sep 30, 2022 | 1.18% |
| Jun 30, 2022 | -2.78% |
| Mar 31, 2022 | 2.28% |
| Dec 31, 2021 | 0.15% |
| Sep 30, 2021 | 6.23% |